GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mouse protein arginine methyltransferase 7 in complex with sah

Analyse Crystal structure of mouse protein arginine methyltransferase 7 in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4C4A
Type
protein
Length
641 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein arginine N-methyltransferase 7
EC
2.1.1.-, 2.1.1.125, 2.1.1.126
UniProt
Q922X9
Ligands
SAH, DMX, ZN
Pockets
6 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein arginine N-methyltransferase 7 (EC 2.1.1.-, 2.1.1.125, 2.1.1.126)protein64127% helix, 34% strandQ922X9

Ligands and binding sites

  • SAH · S-adenosyl-L-homocysteine · ligand · chains A
  • DMX · 3-[benzyl(dimethyl)ammonio]propane-1-sulfonate · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • PG0 · 2-(2-methoxyethoxy)ethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18650.760.80109SAH
21260.650.8829empty
3610.520.8722empty
4600.360.7813empty
5780.330.7517DMX

Compared structures

  • 4C4A · Crystal structure of mouse protein arginine methyltransferase 7 in complex with SAH · the same entry in another collection · chain A against A, TM-score 1.00
  • Q922X9 · AlphaFold monomer V2.0 prediction for protein arginine N-methyltransferase 7 (Q922X9) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.